Karthikeyan Chandrabose
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Also affiliated: Indira Gandhi National Tribal University (2026)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Karthikeyan Chandrabose's research investigates the therapeutic potential of chemical compounds, particularly quinazoline derivatives, in mitigating neurodegenerative conditions. His work includes exploring the effects of N-(3,4-dimethoxy phenyl)-6,7-dimethoxyquinazoline-4-amine (TKM01) in an aluminum-induced Alzheimer's disease-like model in zebrafish. This research aims to identify neuroprotective agents and understand their mechanisms of action in disease models. Chandrabose also studies the amelioration of comorbid depression and anxiety disorders through combination therapies, and he is exploring macropinocytosis-driven approaches for drug delivery in cancer treatment. His publications reflect a focus on neurological disorders, neuroprotection, and advanced therapeutic strategies.
Metrics
- Publications: 4
Selected Publications
-
COMBINATION THERAPY OF IMIPRAMINE AND QUETIAPINE IN AMELIORATION OF COMORBID DEPRESSION AND ANXIETY DISORDERS (2026)
-
A Macropinocytosis-Driven Approach for Efficient Delivery of Small- and Macromolecular Cancer Therapeutics in Cancer (Abstract ID: 227830) (2026)
-
Foreword (2026)
Collaboration Network
Top Collaborators
- A Macropinocytosis-Driven Approach for Efficient Delivery of Small- and Macromolecular Cancer Therapeutics in Cancer (Abstract ID: 227830)
- A Macropinocytosis-Driven Approach for Efficient Delivery of Small- and Macromolecular Cancer Therapeutics in Cancer (Abstract ID: 227830)
- A Macropinocytosis-Driven Approach for Efficient Delivery of Small- and Macromolecular Cancer Therapeutics in Cancer (Abstract ID: 227830)
- A Macropinocytosis-Driven Approach for Efficient Delivery of Small- and Macromolecular Cancer Therapeutics in Cancer (Abstract ID: 227830)
- COMBINATION THERAPY OF IMIPRAMINE AND QUETIAPINE IN AMELIORATION OF COMORBID DEPRESSION AND ANXIETY DISORDERS
- COMBINATION THERAPY OF IMIPRAMINE AND QUETIAPINE IN AMELIORATION OF COMORBID DEPRESSION AND ANXIETY DISORDERS
- COMBINATION THERAPY OF IMIPRAMINE AND QUETIAPINE IN AMELIORATION OF COMORBID DEPRESSION AND ANXIETY DISORDERS
Similar Researchers
Based on overlapping research topics